Literature DB >> 18410989

Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease.

Isao Tawara1, Yoshinobu Maeda, Yaping Sun, Kathleen P Lowler, Chen Liu, Tomomi Toubai, Andrew N J McKenzie, Pavan Reddy.   

Abstract

The role of T helper (Th) 1 and Th2 polarization in acute graft-vs-host-disease (GVHD) is unclear. We investigated the role of Th2 cytokine secretion by utilizing donor T cells that cannot make interleukin (IL)-4, IL-5, IL-9, and IL-13 from quadruple cytokine-deficient (Quad-KO) animals in a well-characterized BALB/c-->C57BL/6 model of allogeneic bone marrow transplantation. B6 recipients of BALB/c Quad-KO T cells demonstrated greater clinical severity, target organ damage, and mortality from GVHD than recipients of BALB/c wild-type (WT) T cells. When compared with donor T cells that are deficient in signal transducers and activators of transcription 6 signaling or the signature Th2 cytokine, IL-4, Quad-KO T cells demonstrated greater GVHD mortality. Mechanistic studies demonstrated that Quad-KO T cells demonstrated enhanced T-cell proliferation than WT T cells when stimulated with either allogeneic antigen-presenting cells or with nonspecific stimuli, such as anti-CD3 monoclonal antibody. Quad-KO T cells also secreted greater amounts of Th1 cytokines and IL-17 compared to WT T cells. Deficiency of Th2 cytokines, however, did not alter the allospecific cytotoxic responses, the numbers of immunoregulatory CD4(+)CD25(+) Foxp3(+) T cells or their suppressive functions. Our data thus unequivocally demonstrate that deficiency of the four classical Th2 cytokine enhances T-cell proliferative responses and aggravates GVHD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18410989      PMCID: PMC2603625          DOI: 10.1016/j.exphem.2008.02.010

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  22 in total

Review 1.  Signaling and transcription in T helper development.

Authors:  K M Murphy; W Ouyang; J D Farrar; J Yang; S Ranganath; H Asnagli; M Afkarian; T L Murphy
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment.

Authors:  W Ouyang; M Löhning; Z Gao; M Assenmacher; S Ranganath; A Radbruch; K M Murphy
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

3.  IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13.

Authors:  Padraic G Fallon; Helen E Jolin; Philippa Smith; Claire L Emson; Michael J Townsend; Rosie Fallon; Philip Smith; Andrew N J McKenzie
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

Review 4.  The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.

Authors:  G R Hill; J L Ferrara
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

5.  Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets.

Authors:  B Nikolic; S Lee; R T Bronson; M J Grusby; M Sykes
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

6.  Mast cells are essential intermediaries in regulatory T-cell tolerance.

Authors:  Li-Fan Lu; Evan F Lind; David C Gondek; Kathy A Bennett; Michael W Gleeson; Karina Pino-Lagos; Zachary A Scott; Anthony J Coyle; Jennifer L Reed; Jacques Van Snick; Terry B Strom; Xin Xiao Zheng; Randolph J Noelle
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

7.  IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development.

Authors:  J M Townsend; G P Fallon; J D Matthews; P Smith; E H Jolin; N A McKenzie
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

8.  T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6.

Authors:  A L Dent; J Hu-Li; W E Paul; L M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

9.  Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis.

Authors:  P Reddy; T Teshima; M Kukuruga; R Ordemann; C Liu; K Lowler; J L Ferrara
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

10.  Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses.

Authors:  G J McKenzie; P G Fallon; C L Emson; R K Grencis; A N McKenzie
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

View more
  22 in total

1.  Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes.

Authors:  Keli L Hippen; Christoph Bucher; Dawn K Schirm; Amanda M Bearl; Ty Brender; Kathy A Mink; Kimberly S Waggie; Regis Peffault de Latour; Anne Janin; Julie M Curtsinger; Stacey R Dillon; Jeffrey S Miller; Gerard Socie; Bruce R Blazar
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

Review 2.  Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.

Authors:  James M Coghill; Stefanie Sarantopoulos; Timothy P Moran; William J Murphy; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2011-01-18       Impact factor: 22.113

3.  Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice.

Authors:  Yu Yu; Dapeng Wang; Chen Liu; Kane Kaosaard; Kenrick Semple; Claudio Anasetti; Xue-Zhong Yu
Journal:  Blood       Date:  2011-08-19       Impact factor: 22.113

4.  Host basophils are dispensable for induction of donor T helper 2 cell differentiation and severity of experimental graft-versus-host disease.

Authors:  Isao Tawara; Evelyn Nieves; Chen Liu; Rebecca Evers; Tomomi Toubai; Yaping Sun; Mariem Alrubaie; Pavan Reddy
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-25       Impact factor: 5.742

Review 5.  HDAC inhibition and graft versus host disease.

Authors:  Sung Choi; Pavan Reddy
Journal:  Mol Med       Date:  2011-01-08       Impact factor: 6.354

6.  Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.

Authors:  Dominik Schneidawind; Jeanette Baker; Antonio Pierini; Corina Buechele; Richard H Luong; Everett H Meyer; Robert S Negrin
Journal:  Blood       Date:  2015-03-20       Impact factor: 22.113

7.  Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.

Authors:  Tangsheng Yi; Ying Chen; Lin Wang; Gong Du; Daniel Huang; Dongchang Zhao; Heather Johnston; James Young; Ivan Todorov; Dale T Umetsu; Lieping Chen; Yoichiro Iwakura; Fouad Kandeel; Stephen Forman; Defu Zeng
Journal:  Blood       Date:  2009-07-14       Impact factor: 22.113

8.  Acute eosinophilic pneumonia is a non-infectious lung complication after allogeneic hematopoietic stem cell transplantation.

Authors:  Mayumi Yoshimi; Yasuhito Nannya; Takuro Watanabe; Takashi Asai; Motoshi Ichikawa; Go Yamamoto; Keiki Kumano; Akira Hangaishi; Yoichi Imai; Tsuyoshi Takahashi; Shigeru Chiba; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2009-01-10       Impact factor: 2.490

9.  TLR4 inactivation protects from graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Yi Zhao; Qiuyan Liu; Li Yang; Donghua He; Lijuan Wang; Jun Tian; Yi Li; Fuming Zi; Hanying Bao; Yang Yang; Yuanyuan Zheng; Jimin Shi; Xingkui Xue; Zhen Cai
Journal:  Cell Mol Immunol       Date:  2012-12-24       Impact factor: 11.530

10.  Insufficiency of Janus kinase 2-autonomous leptin receptor signals for most physiologic leptin actions.

Authors:  Scott Robertson; Ryoko Ishida-Takahashi; Isao Tawara; Jiang Hu; Christa M Patterson; Justin C Jones; Rohit N Kulkarni; Martin G Myers
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.